ExodusPoint Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-104,663
| Closed | -$11.7M | – | 1562 |
|
2025
Q1 | $11.7M | Buy |
+104,663
| New | +$11.7M | 0.12% | 155 |
|
2024
Q4 | – | Sell |
-148,038
| Closed | -$12.4M | – | 1579 |
|
2024
Q3 | $12.4M | Buy |
148,038
+100,282
| +210% | +$8.41M | 0.08% | 169 |
|
2024
Q2 | $3.28M | Buy |
+47,756
| New | +$3.28M | 0.02% | 502 |
|
2023
Q3 | – | Sell |
-279,278
| Closed | -$21.5M | – | 1786 |
|
2023
Q2 | $21.5M | Buy |
+279,278
| New | +$21.5M | 0.17% | 77 |
|
2023
Q1 | – | Sell |
-129,276
| Closed | -$11.1M | – | 1792 |
|
2022
Q4 | $11.1M | Buy |
+129,276
| New | +$11.1M | 0.16% | 141 |
|
2022
Q3 | – | Sell |
-5,655
| Closed | -$350K | – | 1987 |
|
2022
Q2 | $350K | Sell |
5,655
-25,128
| -82% | -$1.56M | ﹤0.01% | 1429 |
|
2022
Q1 | $1.83M | Buy |
+30,783
| New | +$1.83M | 0.02% | 771 |
|
2021
Q1 | – | Sell |
-53,683
| Closed | -$3.13M | – | 2219 |
|
2020
Q4 | $3.13M | Buy |
53,683
+42,591
| +384% | +$2.48M | 0.03% | 356 |
|
2020
Q3 | $701K | Sell |
11,092
-16,198
| -59% | -$1.02M | 0.01% | 782 |
|
2020
Q2 | $2.1M | Sell |
27,290
-22,574
| -45% | -$1.74M | 0.05% | 386 |
|
2020
Q1 | $3.73M | Buy |
+49,864
| New | +$3.73M | 0.2% | 69 |
|
2019
Q4 | – | Sell |
-29,839
| Closed | -$1.89M | – | 1608 |
|
2019
Q3 | $1.89M | Sell |
29,839
-43,343
| -59% | -$2.75M | 0.07% | 230 |
|
2019
Q2 | $4.94M | Sell |
73,182
-18,634
| -20% | -$1.26M | 0.2% | 57 |
|
2019
Q1 | $5.97M | Buy |
91,816
+77,852
| +558% | +$5.06M | 0.44% | 29 |
|
2018
Q4 | $873K | Buy |
+13,964
| New | +$873K | 0.06% | 91 |
|